← All trials
NCT04673383
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 4, 2021
- Primary completion
- Oct 1, 2022
- Completion date
- Feb 1, 2023
- First posted
- Dec 17, 2020
- Last posted
- Sep 14, 2021
- Enrollment
- 68
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Small Pharma LtdLead sponsor
- Hammersmith Medicines ResearchOverall official - principal investigator
- Imperial College LondonOverall official - principal investigator
- Oxford Therapeutics Consulting LimitedStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.